KDM1A and neuroblastoma: LSD1 inhibition with siRNA and small molecule inhibitors from the monoamine oxidase inhibitor (MAOI) category (pargyline, tranylcypromine, and clorgyline) causes differentiation and inhibits the growth of neuroblastoma cell lines and xenografts [15].